GNOM

Global X Genomics & Biotechnology ETF · NAS

Category Equity
Expense Ratio 0.5%
Listing Date Apr 09, 2019
Volume 111,673.0
Market Cap (AUM) $68.94M

Performance

-5.27%

+1.33%

-14.45%

-2.75%

-14.43%

YTD

-11.16%

Top Holdings

Name
Symbol
%Assets
Avidity Biosciences IncRNA5.30%
Moderna, Inc.MRNA4.81%
Natera, Inc.NTRA4.63%
Bio-Techne CorporationTECH4.61%
Intellia Therapeutics, Inc.NTLA4.53%
CRISPR Therapeutics AGCRSP4.27%
Alnylam Pharmaceuticals, IncALNY4.20%
QIAGEN NVQGEN4.14%
Myriad Genetics, Inc.MYGN3.98%
Arrowhead Pharmaceuticals, Inc.ARWR3.97%

Advanced Technical Analysis

Technical Analysis of GNOM 2024-12-20

The stock's Moving Average Score of 10 indicates a strong bearish sentiment, while the Oscillators Score of 53 suggests a neutral stance. Overall, the Technical Score of 31 reinforces the bearish outlook, indicating that the stock may face downward pressure in the near term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Recent News & Updates

2022-01-26 00:38
Sightline Wealth Advisors, LLC Buys iShares 0-5 Year TIPS Bond ETF, ARK Genomic Revolution ETF, ...(Yahoo Finance)
2022-01-19 20:38
Archford Capital Strategies, LLC Buys iShares Short Treasury Bond ETF, Global X Autonomous ...(Yahoo Finance)
2022-01-13 00:38
McGuire Investment Group, LLC Buys SPDR Bloomberg 1-3 Month T-Bill ETF, WisdomTree Floating ...(Yahoo Finance)
2020-11-25 02:37
ETF Wrap: A very ETF Thanksgiving, and tax season too(Marketwatch)
2020-08-27 05:31
This High-Growth Tech Stock Play Is Up 96% As Cloud Computing Stocks Push Higher(Investors)
2020-06-07 16:00
Thematic ETFs The New Sectors?(Yahoo Finance)
2020-06-04 00:20
ETFs Under $20 From 5 Hottest Zones(Yahoo Finance)
2020-05-26 00:50
3 Genomics ETFs Worth Jumping For(Yahoo Finance)
2020-05-25 19:40
Genomics ETF (GNOM) Hits New 52-Week High(Yahoo Finance)
2020-01-08 22:13
Why This Thematic Healthcare Could be a January Winner(Yahoo Finance)
2019-12-26 01:30
4 Sector ETFs That Beat the Market in Q4(Yahoo Finance)
2019-12-18 00:41
Best & Worst Monthly Performers: December 18 Edition(Yahoo Finance)
2019-12-11 19:00
Beyond Biotech, 5 ETFs Up At Least 10% in Q4(Yahoo Finance)
2019-12-04 09:23
Hedge Funds Have Never Been This Bullish On PTC Therapeutics, Inc. (PTCT)(Yahoo Finance)
2019-11-28 23:15
Biotech Tops in November: Best ETFs & Stocks(Yahoo Finance)
2019-11-25 05:55
Genomics ETFs Surge on CRISPR's Gene Editing Progress(Yahoo Finance)
2019-11-20 23:15
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD(Yahoo Finance)
2019-10-29 22:43
Healthcare ETFs Win in October: Here's Why(Yahoo Finance)
2019-10-09 21:25
This High Growth ETF May Not Be As Pricey As You Think(Yahoo Finance)
2019-09-06 03:07
ETFs Poised to Benefit from Gene Editing Revolution(Yahoo Finance)
2019-09-05 23:09
A Young Biotech ETF With Plenty of Potential(Yahoo Finance)
2019-09-04 03:18
ETFs to Gain From the Booming Genomics Market(Yahoo Finance)
2019-08-05 00:00
7 Biotech ETFs That Should Remain Healthy(Yahoo Finance)
2019-08-01 00:10
Inside the Allure of a Genomics ETF(Yahoo Finance)
2019-06-24 00:17
A New ETF For Hot Corners of The Biotech Market(Yahoo Finance)
2019-06-18 23:15
Wall Street on Pace for Best June in Decades: 5 Best ETFs(Yahoo Finance)
2019-04-15 02:00
Four Companies Could Power The New Genomics ETF(Yahoo Finance)
2019-04-11 02:18
A New Biotech ETF For an Exciting Theme(Yahoo Finance)
2019-04-09 20:01
Get In On Genomics With This New ETF(Yahoo Finance)
2019-04-09 05:15
Global X Debuts Pure Play Genomics ETF GNOM(Yahoo Finance)
2019-04-08 22:03
Global X Launches GNOM: An ETF targeting the Transformative Genomics Industry(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.